Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




PET/CT Technology Used to Improve Breast Cancer Detection and Therapy

By MedImaging staff writers
Posted on 21 Jul 2008
The first scans of patients from a custom-built scanner combining positron emission tomography (PET) and computed tomography (CT) technologies indicate that these scans could significantly improve breast cancer imaging capabilities and lead to more targeted treatment options, according to researchers.

Researchers presented their findings at the Society of Nuclear Medicine's (SNM) 55th annual meeting, held in June 2008 in New Orleans, LA, USA. More...
The prototype scanner is designed to help physicians determine stages of breast cancer in patients already diagnosed with the disease, instead of as a mammography-screening tool.

"The use of dedicated breast PET/CT scanners could really open up new possibilities in treatment for women with breast cancer,” said Dr. Ramsey Badawi, assistant professor of radiology, University of California--Davis Medical Center (Sacramento, CA, USA) and lead investigator for the study. "Using this noninvasive technology, physicians can get much more accurate images of tumors, especially small tumors, than conventional full-body PET scans. This will enable physicians to determine the stage of the cancer and determine courses of treatment more accurately.”

Moreover, the technology could ultimately be used to detect early whether drug treatments are effective in individual patients. "One great advantage for doctors will be to better plan breast cancer surgeries,” said Dr. Badawi. "Using a PET/CT scan, doctors should be able to determine whether drug treatments are working before performing surgery, thus eliminating unnecessary mastectomies. Medical professionals will also have a much better sense of the exact location and size of tumors.”

The technology also can be used to measure the effectiveness of new drugs and molecular imaging agents for detecting and treating breast cancer, another vital component to advancing individualized medicine for patients. Furthermore, the dedicated breast PET/CT scanner can detect the difference between malignancies and benign tissues such as cysts or scars, eliminating many unnecessary biopsies.

The prototype breast PET/CT scanner evaluated by Dr. Badawi and his team consists of two adjustable planar heads. Patients lie prone as the PET/CT system rotate around the freely suspended breast. PET and CT data are used to produce detailed three-dimensional images. Many women could also find the new technology more comfortable, because it does not require the breast to be compressed during the scan.

The first patient to be scanned with the customized breast PET/CT scanner was a 49-year-old woman with a palpable mass on her right breast. The breast PET/CT scan effectively detected breast cancer, which was later confirmed by biopsy. The results indicated that PET/CT images of the uncompressed breast are accurate and provide clinically relevant data.


Related Links:
University of California--Davis Medical Center

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.